Clinical features and outcomes in patients with disseminated toxoplasmosis admitted to intensive care: A multicenter study

Clinical Infectious Diseases

Volumn 57, Issue 11, 2013, Pages 1535-1541

  Schmidt, Matthieu ^a   Sonneville, Romain ^b   Schnell, David ^c   Bigé, Naike ^d   Hamidfar, Rebecca ^e   Mongardon, Nicolas ^f   Castelain, Vincent ^g   Razazi, Keyvan ^h   Marty, Antoine ⁱ   Vincent, François ^j   Dres, Martin ^k   Gaudry, Stephane ^l   Luyt, Charles Edouard ^a   Das, Vincent ^m   Micol, Jean Baptiste ⁱ   Demoule, Alexandre ^a   Mayaux, Julien ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e HÔPITAL MICHALLON   (France)

^f NONE   (France)

^g HÔPITAL DE HAUTEPIERRE   (France)

^h HENRI MONDOR HOSPITAL   (France)

ⁱ INSTITUT GUSTAVE ROUSSY   (France)

^j AVICENNE HOSPITAL   (France)

^k BICÊTRE HOSPITAL   (France)

^l HÔPITAL LOUIS MOURIER   (France)

^m Centre Hospitalier Intercommunal Andre Gregoire   (France)

more..

Author keywords

Allogeneic stem cell transplant; Disseminated toxoplasmosis; Immunosuppression; Multiorgan failure; Outcome assessment

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; HYPERTENSIVE FACTOR; PYRIMETHAMINE; PYRIMETHAMINE SULFADIAZINE;

ACUTE RESPIRATORY FAILURE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; DISSEMINATED TOXOPLASMOSIS; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INTENSIVE CARE UNIT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; SHOCK; TOXOPLASMOSIS;

ALLOGENEIC STEM CELL TRANSPLANT; DISSEMINATED TOXOPLASMOSIS; IMMUNOSUPPRESSION; MULTIORGAN FAILURE; OUTCOME ASSESSMENT;

ADULT; FEMALE; FRANCE; HUMANS; IMMUNOCOMPROMISED HOST; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; PROGNOSIS; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; TOXOPLASMOSIS; TREATMENT OUTCOME;

EID: 84887964798     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit557     Document Type: Article

References (31)

1. Slavin MA, Meyers JD, Remington J.S., Hackman RC Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994; 13: 549-57.
2. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-76.
3. Bretagne S, Costa JM, Fleury-Feith J, Poron F., Dubreuil-Lemaire ML, Vidaud M. Quantitative competitive PCR with bronchoalveolar lavage fluid for diagnosis of toxoplasmosis in AIDS patients. J Clin Microbiol 1995; 33: 1662-4.
4. Bretagne S, Costa JM, Kuentz M, et al Late toxoplasmosis evidenced by PCR in a marrow transplant recipient. Bone Marrow Transplant 1995; 15: 809-11.
5. Martino R, Bretagne S, Einsele H., et al Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 2005; 40: 67-78.
6. Sonneville R, Schmidt M, Messika J., et al Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis. Neurology 2012; 79: 1762-6.
7. Mendelson MH, Finkel LJ, Meyers B.R., Lieberman JP, Hirschman SZ Pulmonary toxoplasmosis in AIDS. Scand J Infect Dis 1987; 19: 703-6.
8. Pomeroy C, Filice GA Pulmonary toxoplasmosis: a review. Clin Infect Dis 1992; 14: 863-70.
9. Martino R, Maertens J, Bretagne S., et al Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 2000; 31: 1188-95.
10. Sing A, Leitritz L, Roggenkamp A., et al Pulmonary toxoplasmosis in bone marrow transplant recipients: report of two cases and review. Clin Infect Dis 1999; 29: 429-33.
11. Busemann C, Ribback S, Zimmermann K., et al Toxoplasmosis after allogeneic stem cell transplantation - A single centre experience. Ann Hematol 2012; 91: 1081-9.
12. Lucet JC, Bailly MP, Bedos J.P., Wolff M., Gachot B, Vachon F. Septic shock due to toxoplasmosis in patients infected with the human immunodeficiency virus. Chest 1993; 104: 1054-8.
13. Reischl U, Bretagne S, Krüger D, Ernault P., Costa J-M. Comparison of two DNA targets for the diagnosis of toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect Dis 2003; 3: 7.
14. Menotti J, Vilela G, Romand S., et al Comparison of PCR-enzymelinked immunosorbent assay and real-time PCR assay for diagnosis of an unusual case of cerebral toxoplasmosis in a stem cell transplant recipient. J Clin Microbiol 2003; 41: 5313-6.
15. Costa JM, Pautas C, Ernault P., Foulet F, Cordonnier C, Bretagne S. Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes. J Clin Microbiol 2000; 38: 2929-32.
16. Derouin F, Sarfati C, Beauvais B., Iliou MC, Dehen L, Lariviere M. Laboratory diagnosis of pulmonary toxoplasmosis in patients with acquired immunodeficiency syndrome. J Clin Microbiol 1989; 27: 1661-3.
17. Le Gall J.R., Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-63.
18. Vincent JL, Moreno R, Takala J., et al The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-10.
19. Janka GE. Hemophagocytic syndromes. Blood Rev 2007; 21: 245-53.
20. Chandrasekar PH, Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team. Bone Marrow Transplant 1997; 19: 685-9.
21. Passweg JR, Baldomero H, Gratwohl A., et al The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012; 47: 906-23.
22. Duband S, Cornillon J, Tavernier E., Dumollard J-M, Guyotat D, Péoc'h M. Toxoplasmosis with hemophagocytic syndrome after bone marrow transplantation: diagnosis at autopsy. Transpl Infect Dis 2008; 10: 372-4.
23. Delhaes L, Mraz J-C, Fréalle E, et al Severe pulmonary toxoplasmosis after allo-SCT in two patients: from Toxoplasma genotyping to clinical management. Bone Marrow Transplant 2010; 45: 580-3.
24. Fricker-Hidalgo H., Bulabois C-E, Brenier-Pinchart M-P, et al. Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques. Clin Infect Dis 2009; 48: e9-15.
25. Bautista G, Ramos A, Forés R, et al Toxoplasmosis in cord blood transplantation recipients. Transpl Infect Dis 2012; 14: 496-501.
26. Fernàndez-Sabé N, Cervera C, Fariñas MC, et al. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clin Infect Dis 2012; 54: 355-61.
27. Aoun M, Georgala A, Mboumi K., et al Changing the outcome of toxoplasmosis in bone marrow transplant recipients. Int J Antimicrob Agents 2006; 27: 570-2.
28. Tomblyn M, Chiller T, Einsele H., et al Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143-238.
29. Katlama C, Mouthon B, Gourdon D., Lapierre D, Rousseau F. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group. AIDS 1996; 10: 1107-12.
30. Tabbara KF, Hammouda E, Tawfik A., Al-Omar OM, Abu El-Asrar AM. Azithromycin prophylaxis and treatment of murine toxoplasmosis. Saudi Med J 2005; 26: 393-7.
31. Godofsky EW. Treatment of presumed cerebral toxoplasmosis with azithromycin. N Engl J Med 1994; 330: 575-6.